"Half the dsylipidemia of insulin resistance" is the dsylipidemia of insulin-resistant blacks

Ethnicity and Disease

Volumn 19, Issue 4, 2009, Pages 462-465

  Sumner, Anne E ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Blacks; High density lipoprotein cholesterol; Insulin resistance; Metabolic syndrome; Triglyceride

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; HIGH DENSITY LIPOPROTEIN;

CARDIOVASCULAR DISEASE; DYSLIPIDEMIA; HEALTH HAZARD; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPOGENESIS; METABOLIC SYNDROME X; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; AFRICAN AMERICAN; ARTICLE; BLOOD; ETHNOLOGY; HYPERTRIGLYCERIDEMIA; METABOLISM; PHYSIOLOGY;

AFRICAN AMERICANS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIPOPROTEINS, HDL; METABOLIC SYNDROME X; TRIGLYCERIDES;

EID: 77949319461     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (23)

1. Sumner AE, Cowie CC. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis. 2008;196: 696-703.
2. Sumner AE, Finley KB, Genovese DJ, Criqui MH, Boston RC. Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans. Arch Intern Med. 2005;165: 1395-1400.
3. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28: 629-636.
4. Park Y-W, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome, prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163:427-436.
5. Kahn HS. The lipid accumulation product is better than BMI for identifying diabetes. Diabetes Care. 2006;29:151-153.
6. Kahn HS, Cheng YJ, Thompson TJ, Imperatore G, Gregg EW. Two risk scoring systems for predicting incident diabetes mellitus in U.S. adults age 45 to 64 years. Ann Intern Med. 2009;150:741-751.
7. Kanaya AM, Wassel Fyr CL, de Rekeneire N, et al. Predicting the development of diabetes in older adults. Diabetes Care. 2005;28:404-408.
8. Lemieux I, Pascot A, Couillard C, et al. Hypertriglyceridemic waist, a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small dense LDL) in men? Circulation. 2000;102:179-184.
9. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven GM. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003;139:802-809.
10. Meigs JB, Williams K, Sullivan LM, et al. Using metabolic syndrome traits for efficient detection of impaired glucose tolerance. Diabetes Care. 2004;27:1417-1426. (Pubitemid 38679992)
11. St. Pierre J, Lemieux I, Perron P, et al. Relationship of the "hypertriglyceridemic waist" phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus. Am J Cardiol. 2007;99:369-373.
12. Tanko LB, Bagger YZ, Qin G, Alexandersen P, Larsen PJ, Christiansen C. Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation. 2005;111:1883-1890. (Pubitemid 40570207)
13. Wilson PWF, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino RB. Prediction of incident diabetes mellitus in middle-aged adults. Arch Intern Med. 2007;167:1068-1074.
14. Adiels M, Olofsson S-O, Taskinen M-R, Boren J. Overproduction of very low-density lipoproteins is the hallmark of the dsylipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28:1225-1236.
15. AHA Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics 2009 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation. 2009;119:e21-e181.
16. Cowie CC, Rust KF, Byrd-Holt D, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population, national health and nutritution examination survey 1999-2002. Diabetes Care. 2006;29: 1263-1268.
17. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults, findings from the third national health and nutrition examination survey. JAMA. 2002; 287:356-359. (Pubitemid 34251969)
18. Despres J-P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444: 881-887.
19. Guerrero R, Vega GL, Grundy SM, Browning JD. Ethnic differences in hepatic steatosis: an insulin resistance paradox? Hepatology. 2009; 49:791-801.
20. Despres J-P, Couillard C, Gagnon J, et al. Race, visceral adipose rissue, plasma lipids, and lipoprotein lipase activity in men and women, the health, risk factors, exercise training, and genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol. 2000;20:1932-1938. (Pubitemid 30644643)
21. Florez H, Mendez A, Casanova-Romero P, et al. Increased apolipoprotein C-III levels associated with insulin resistance contribute to dsylipidemia in normoglycemic and diabetic subjects from a triethnic population. Atherosclerosis. 2006;188:134-141. (Pubitemid 44142528)
22. Maheux P, Azhar S, Kern PA, Chen Y-DI, Reaven GM. Relationship between insulin-mediated glucose disposal and regulation of plasma and adipose tissue lipoprotein lipase. Diabetologia. 1997;40:850-858. (Pubitemid 27306965)
23. Sumner AE, Vega GL, Genovese DJ, Finley KB, Bergman RN, Boston RC. Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase. Metabolism. 2005;54:902-909.